DISHMAN CARBOGEN AMCIS
|
DISHMAN CARBOGEN AMCIS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 6.21 | 0.21 | -9.79 | -1.90 | 1.15 |
| CEPS(Rs) | 27.82 | 18.94 | 10.04 | 16.00 | 20.77 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 425.82 | 371.91 | 358.90 | 370.51 | 353.89 |
| Tax Rate(%) | 7.10 | 83.22 | -25.51 | 45.41 | 523.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.29 | 16.22 | 10.09 | 13.77 | 15.21 |
| EBIT Margin(%) | 9.52 | 6.59 | -0.09 | 1.29 | 2.46 |
| Pre Tax Margin(%) | 3.58 | 0.71 | -4.67 | -2.26 | -0.20 |
| PAT Margin (%) | 3.32 | 0.12 | -5.87 | -1.24 | 0.84 |
| Cash Profit Margin (%) | 14.88 | 10.95 | 6.02 | 10.40 | 15.21 |
| Performance Ratios | |||||
| ROA(%) | 0.89 | 0.03 | -1.61 | -0.33 | 0.21 |
| ROE(%) | 1.56 | 0.06 | -2.68 | -0.52 | 0.32 |
| ROCE(%) | 3.21 | 2.31 | -0.03 | 0.43 | 0.76 |
| Asset Turnover(x) | 0.27 | 0.28 | 0.28 | 0.27 | 0.25 |
| Sales/Fixed Asset(x) | 0.26 | 0.26 | 0.26 | 0.27 | 0.26 |
| Working Capital/Sales(x) | 5.58 | 9.84 | -4.18 | 20.11 | 5.11 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 3.92 | 3.85 | 3.78 | 3.75 | 3.92 |
| Receivable days | 83.29 | 77.38 | 74.96 | 80.42 | 76.23 |
| Inventory Days | 119.47 | 120.02 | 117.68 | 109.59 | 98.96 |
| Payable days | 197.26 | 172.74 | 141.75 | 145.87 | 147.90 |
| Valuation Parameters | |||||
| PER(x) | 20.92 | 1,053.08 | - | - | 161.20 |
| PCE(x) | 4.67 | 11.49 | 23.47 | 7.79 | 8.92 |
| Price/Book(x) | 0.31 | 0.59 | 0.66 | 0.34 | 0.52 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.30 | 1.84 | 2.01 | 1.49 | 1.94 |
| EV/Core EBITDA(x) | 6.15 | 10.17 | 16.67 | 9.97 | 11.08 |
| EV/EBIT(x) | 13.70 | 27.91 | -2,290.51 | 115.45 | 78.99 |
| EV/CE(x) | 0.40 | 0.63 | 0.69 | 0.47 | 0.60 |
| M Cap / Sales | 0.70 | 1.26 | 1.41 | 0.81 | 1.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.13 | 3.66 | 8.41 | 12.72 | 11.96 |
| Core EBITDA Growth(%) | 26.69 | 55.90 | -12.57 | -3.95 | 19.82 |
| EBIT Growth(%) | 56.11 | 7,906.55 | -107.36 | -40.83 | 401.72 |
| PAT Growth(%) | 2,907.72 | 102.11 | -414.93 | -265.46 | 110.91 |
| EPS Growth(%) | 2,907.70 | 102.11 | -414.94 | -265.46 | 110.91 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.42 | 0.36 | 0.35 | 0.31 | 0.26 |
| Current Ratio(x) | 1.23 | 1.14 | 0.75 | 1.07 | 1.30 |
| Quick Ratio(x) | 0.79 | 0.68 | 0.41 | 0.62 | 0.84 |
| Interest Cover(x) | 1.60 | 1.12 | -0.02 | 0.36 | 0.93 |
| Total Debt/Mcap(x) | 1.36 | 0.61 | 0.53 | 0.93 | 0.49 |
Compare Financial Ratios of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,139.5 Cr | -8.9% | -19.7% | -51.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -8.9% |
-19.7% |
-51.2% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses
